World's Best Scientists 2026 revealed!
Toyomasa Katagiri

Toyomasa Katagiri

D-Index & Metrics

Medicine

D-Index
75
Citations
16161
World Ranking
19229
National Ranking
616

Toyomasa Katagiri publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Toyomasa Katagiri sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 229 publications — 5th percentile

5% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Toyomasa Katagiri D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Toyomasa Katagiri sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 75 D-Index — 6th percentile

6% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Toyomasa Katagiri is affiliated with the University of Tokushima in Japan and has contributed extensively to the fields of biochemistry, genetics, and molecular biology, with a particular focus on medicine. Their research spans several subfields, including molecular biology, oncology, cell biology, genetics, and radiology, nuclear medicine, and imaging.

Their work covers a range of main topics such as peptidase inhibition and analysis, epigenetics and DNA methylation, RNA research and splicing, RNA modifications and cancer, endoplasmic reticulum stress and disease, RNA regulation and disease, and chemical synthesis and analysis.

Katagiri's recent publications include:

  • Large-scale genome-wide association study in a Japanese population identifies novel susceptibility loci across different diseases, 2020, Nature Genetics
  • FZD10-targeted α-radioimmunotherapy with 225Ac-labeled OTSA101 achieves complete remission in a synovial sarcoma model, 2021, Cancer Science
  • Pivotal role for S-nitrosylation of DNA methyltransferase 3B in epigenetic regulation of tumorigenesis, 2023, Nature Communications
  • Dynamic movement of the Golgi unit and its glycosylation enzyme zones, 2024, Nature Communications
  • p53-independent tumor suppression by cell-cycle arrest via CREB/ATF transcription factor OASIS, 2023, Cell Reports

Frequent co-authors collaborating with Katagiri include:

  • Tetsuro Yoshimaru
  • Yosuke Matsushita
  • Satoshi Nagayama
  • Ryo Takata

Their research has been frequently published in venues such as Cancer Science, Cancer Medicine, Nature Communications, ChemistryEurope, and bioRxiv (Cold Spring Harbor Laboratory).

Best Publications

  • Glypican-3, overexpressed specifically in human hepatocellular carcinoma, is a novel tumor marker.

    Tetsuya Nakatsura;Yoshihiro Yoshitake;Satoru Senju;Mikio Monji

  • Large-scale genome-wide association study in a Japanese population identifies novel susceptibility loci across different diseases

    Kazuyoshi Ishigaki;Kazuyoshi Ishigaki;Masato Akiyama;Masahiro Kanai;Masahiro Kanai;Atsushi Takahashi

  • Expression profiles of non-small cell lung cancers on cDNA microarrays: Identification of genes for prediction of lymph-node metastasis and sensitivity to anti-cancer drugs

    Takefumi Kikuchi;Takefumi Kikuchi;Yataro Daigo;Toyomasa Katagiri;Tatsuhiko Tsunoda

  • Genome-wide cDNA microarray analysis of gene expression profiles in pancreatic cancers using populations of tumor cells and normal ductal epithelial cells selected for purity by laser microdissection

    Toru Nakamura;Yoichi Furukawa;Hidewaki Nakagawa;Tatsuhiko Tsunoda

  • Enhanced SMYD3 expression is essential for the growth of breast cancer cells.

    Ryuji Hamamoto;Fabio Pittella Silva;Masataka Tsuge;Toshihiko Nishidate

  • Mutation analysis in the BRCA2 gene in primary breast cancers.

    Yoshio Miki;Toyomasa Katagiri;Fujio Kasumi;Takamasa Yoshimoto

  • Predicting Response to Methotrexate, Vinblastine, Doxorubicin, and Cisplatin Neoadjuvant Chemotherapy for Bladder Cancers Through Genome-Wide Gene Expression Profiling

    R. Takata;T. Katagiri;M. Kanehira;T. Tsunoda

  • An Integrated Database of Chemosensitivity to 55 Anticancer Drugs and Gene Expression Profiles of 39 Human Cancer Cell Lines

    Shingo Dan;Tatsuhiko Tsunoda;Osamu Kitahara;Rempei Yanagawa

  • Molecular features of the transition from prostatic intraepithelial neoplasia (PIN) to prostate cancer: genome-wide gene-expression profiles of prostate cancers and PINs.

    Shingo Ashida;Hidewaki Nakagawa;Toyomasa Katagiri;Mutsuo Furihata

  • Genome-wide cDNA Microarray Screening to Correlate Gene Expression Profiles with Sensitivity of 85 Human Cancer Xenografts to Anticancer Drugs

    Hitoshi Zembutsu;Yasuyuki Ohnishi;Tatsuhiko Tsunoda;Yoichi Furukawa

  • Genome-wide analysis of gene expression in intestinal-type gastric cancers using a complementary DNA microarray representing 23,040 genes.

    Suguru Hasegawa;Yoichi Furukawa;Meihua Li;Seiji Satoh

  • CDC20, a potential cancer therapeutic target, is negatively regulated by p53.

    T Kidokoro;C Tanikawa;Y Furukawa;T Katagiri

  • Laser Capture Microdissection and Microarray Expression Analysis of Lung Adenocarcinoma Reveals Tobacco Smoking- and Prognosis-related Molecular Profiles

    Koh Miura;Elise D. Bowman;Richard Simon;Amy C. Peng

  • Therapeutic potential of antibodies against FZD10, a cell-surface protein, for synovial sarcomas

    Satoshi Nagayama;Chikako Fukukawa;Toyomasa Katagiri;Takeshi Okamoto

  • Molecular features of triple negative breast cancer cells by genome-wide gene expression profiling analysis.

    Masato Komatsu;Tetsuro Yoshimaru;Taisuke Matsuo;Kazuma Kiyotani

  • Involvement of maternal embryonic leucine zipper kinase (MELK) in mammary carcinogenesis through interaction with Bcl-G, a pro-apoptotic member of the Bcl-2 family.

    Meng Lay Lin;Jae Hyun Park;Toshihiko Nishidate;Yusuke Nakamura

  • PDZ-Binding Kinase/T-LAK Cell-Originated Protein Kinase, a Putative Cancer/Testis Antigen with an Oncogenic Activity in Breast Cancer

    Jae-Hyun Park;Meng-Lay Lin;Toshihiko Nishidate;Yusuke Nakamura

  • Germline pathogenic variants of 11 breast cancer genes in 7,051 Japanese patients and 11,241 controls.

    Yukihide Momozawa;Yusuke Iwasaki;Michael T. Parsons;Yoichiro Kamatani

  • Cloning and characterization of two novel human cDNAs (NELL1 and NELL2) encoding proteins with six EGF-like repeats.

    Takeshi K. Watanabe;Toyomasa Katagiri;Toyomasa Katagiri;Mikio Suzuki;Mikio Suzuki;Fumio Shimizu

  • Genome-wide analysis of gene expression in synovial sarcomas using a cDNA microarray.

    Satoshi Nagayama;Toyomasa Katagiri;Tatsuhiko Tsunoda;Taisuke Hosaka

Frequent Co-Authors

Yusuke Nakamura
Yusuke Nakamura National Institutes of Biomedical Innovation, Health and Nutrition
Tatsuhiko Tsunoda
Tatsuhiko Tsunoda University of Tokyo
Yataro Daigo
Yataro Daigo Shiga University of Medical Science
Yoshio Miki
Yoshio Miki Tokyo Medical and Dental University
Koichi Matsuda
Koichi Matsuda University of Tokyo
Junya Toguchida
Junya Toguchida Kyoto University
Soumya Raychaudhuri
Soumya Raychaudhuri Brigham and Women's Hospital
Koichi Hirata
Koichi Hirata Sapporo Medical University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in healthcare careers beyond the traditional MD route, there are numerous online degrees and career pathways to consider. Nursing continues to be a popular option, with bridge programs helping registered nurses advance. If cost is a key factor, exploring the average cost of rn to bsn programs can help you gauge affordability.

If you have a non-nursing bachelor’s degree, many institutions now offer non nursing bachelor's to msn online programs, allowing a fast track to advanced nursing roles. For prospective students seeking options with less competitive entry requirements, you may want to look into direct admit nursing programs that simplify the admissions process.

Apart from direct patient care, administrative roles such as medical billing and coding offer strong job prospects and flexibility. You can find several reputable medical billing and coding schools online with financial aid, making it accessible to a wider range of students.

Best Scientists Citing Toyomasa Katagiri

Trending Scientists

Recently Published Articles